605659-03-8 Usage
General Description
4,4-Difluoroaminoethylpiperidine is a chemical compound with the molecular formula C8H15F2N. It is an organofluorine compound that contains a piperidine ring structure with two fluorine atoms and an aminoethyl group attached to the nitrogen atom. 4,4-DIFLUOROAMINOETHYLPIPERIDINE is used in organic synthesis as a building block for the production of various pharmaceuticals, agrochemicals, and advanced materials. It is also used as a reagent in the preparation of various functionalized compounds. The presence of fluorine in the molecule imparts unique properties to the compound, making it valuable for the development of diverse chemical products. Additionally, 4,4-difluoroaminoethylpiperidine may also have potential applications in the field of medicinal chemistry and drug discovery due to its structural features.
Check Digit Verification of cas no
The CAS Registry Mumber 605659-03-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,0,5,6,5 and 9 respectively; the second part has 2 digits, 0 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 605659-03:
(8*6)+(7*0)+(6*5)+(5*6)+(4*5)+(3*9)+(2*0)+(1*3)=158
158 % 10 = 8
So 605659-03-8 is a valid CAS Registry Number.
InChI:InChI=1/C7H14F2N2/c8-7(9)1-4-11(5-2-7)6-3-10/h1-6,10H2
605659-03-8Relevant articles and documents
TYK2 INHIBITORS AND USES THEREOF
-
, (2015/09/28)
The present invention provides compounds, compositions thereof, and methods of using the same for the inhibition of TYK2, and the treatment of TYK2-mediated disorders.
QUINOLONE DERIVATIVES AS FIBROBLAST GROWTH FACTOR INHIBITORS
-
Page/Page column 131, (2014/12/09)
Compounds of formula (Ι') that are Fibroblast Growth Factor Inhibitors (FGFR) and are therefore useful for the treatment of diseases treatable by inhibition of FGFR are disclosed. Also disclosed are pharmaceutical compositions containing such compounds and processes for preparing such compounds.
The discovery of novel indole-2-carboxamides as cannabinoid CB1 receptor antagonists
Cowley, Phillip M.,Baker, James,Barn, David R.,Buchanan, Kirsteen I.,Carlyle, Ian,Clark, John K.,Clarkson, Thomas R.,Deehan, Maureen,Edwards, Darren,Goodwin, Richard R.,Jaap, David,Kiyoi, Yasuko,Mort, Chris,Palin, Ronald,Prosser, Alan,Walker, Glenn,Ward, Nick,Wishart, Grant,Young, Trevor
scheme or table, p. 497 - 501 (2011/02/24)
The discovery and structure-activity relationship of a novel series of indole-2-carboxamide antagonists of the cannabinoid CB1 receptor is disclosed. Compound 26i was found to be a high potency, selective cannabinoid CB1 antagonist.
